Distinguished in Embryonal Tumor with Multilayered Rosettes

Dr. Graeme F. Woodworth

Neurosurgery
University Of Maryland Neurosurgery Associates P A
22 S Green St, 
Baltimore, MD 
Accepting New Patients
Offers Telehealth
Distinguished in Embryonal Tumor with Multilayered Rosettes
University Of Maryland Neurosurgery Associates P A
22 S Green St, 
Baltimore, MD 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Graeme Woodworth is a Neurosurgery provider in Baltimore, Maryland. Dr. Woodworth is rated as a Distinguished provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Glioblastoma, Astrocytoma, Brain Tumor, Awake Craniotomy, and Gastrostomy. Dr. Woodworth is currently accepting new patients.

His clinical research consists of co-authoring 92 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Neurosurgery
Licenses
Neurological Surgery in MD
Hospital Affiliations
University Of Maryland Medical Center
University Of MD Baltimore Washington Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

UNIVERSITY OF MARYLAND NEUROSURGERY ASSOCIATES P A
22 S Green St, Baltimore, MD 21201

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase II Randomized Trial Comparing the Efficacy of Heat Shock Protein-Peptide Complex-96 (HSPPC-96) (NSC #725085, ALLIANCE IND # 15380) Vaccine Given With Bevacizumab Versus Bevacizumab Alone in the Treatment of Surgically Resectable Recurrent Glioblastoma Multiforme (GBM)
A Phase II Randomized Trial Comparing the Efficacy of Heat Shock Protein-Peptide Complex-96 (HSPPC-96) (NSC #725085, ALLIANCE IND # 15380) Vaccine Given With Bevacizumab Versus Bevacizumab Alone in the Treatment of Surgically Resectable Recurrent Glioblastoma Multiforme (GBM)
Enrollment Status: Terminated
Publish Date: January 24, 2025
Intervention Type: Biological, Drug
Study Drugs: HSPPC-96, Bevacizumab
Study Phase: Phase 2
Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier Disruption for the Treatment of High Grade Glioma in Patients Undergoing Standard Chemotherapy
Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier Disruption for the Treatment of High Grade Glioma in Patients Undergoing Standard Chemotherapy
Enrollment Status: Completed
Publish Date: March 05, 2024
Intervention Type: Device
Study Phase: Not Applicable
Assessment of Safety and Feasibility of Exablate Type 2 for Blood-Brain Barrier Disruption (BBBD) With Microbubble Resonators for the Treatment of Recurrent Glioblastoma (rGBM) in Subjects Undergoing Carboplatin Monotherapy
Assessment of Safety and Feasibility of Exablate Type 2 for Blood-Brain Barrier Disruption (BBBD) With Microbubble Resonators for the Treatment of Recurrent Glioblastoma (rGBM) in Subjects Undergoing Carboplatin Monotherapy
Enrollment Status: Active_not_recruiting
Publish Date: March 05, 2024
Intervention Type: Drug, Device
Study Drug: Carboplatin
Study Phase: Phase 1/Phase 2
A Study to Evaluate the Safety and Feasibility of Exablate Model 4000 Type-2 to Temporarily Mediate Blood-Brain Barrier Disruption (BBBD) in Patients With Suspected Infiltrating Glioma in the Setting of Planned Surgical Interventions
A Study to Evaluate the Safety and Feasibility of Exablate Model 4000 Type-2 to Temporarily Mediate Blood-Brain Barrier Disruption (BBBD) in Patients With Suspected Infiltrating Glioma in the Setting of Planned Surgical Interventions
Enrollment Status: Suspended
Publish Date: August 03, 2022
Intervention Type: Device
Study Phase: Not Applicable
View 3 Less Clinical Trials

90 Total Publications

The Deformability of the Mammalian Cell Nucleus is Determined by the Identity of the Lamin Rod Domain.
The Deformability of the Mammalian Cell Nucleus is Determined by the Identity of the Lamin Rod Domain.
Journal: bioRxiv : the preprint server for biology
Published: August 08, 2025
Similar Doctors
Distinguished in Embryonal Tumor with Multilayered Rosettes
Dr. Chetan Bettegowda
Neurosurgery
Distinguished in Embryonal Tumor with Multilayered Rosettes
Dr. Chetan Bettegowda
Neurosurgery

Johns Hopkins University

600 N Wolf St, 
Baltimore, MD 
 (1.9 miles away)
410-955-5000
Languages Spoken:
English, Kannada
See accepted insurances
Accepting New Patients
Offers Telehealth

Chetan Bettegowda is a Neurosurgery provider in Baltimore, Maryland. Dr. Bettegowda is rated as an Elite provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Trigeminal Neuralgia, Astrocytoma, Glioblastoma, Rhizotomy, and Microvascular Decompression. Dr. Bettegowda is currently accepting new patients.

Distinguished in Embryonal Tumor with Multilayered Rosettes
Dr. Jon Weingart
Neurosurgery
Distinguished in Embryonal Tumor with Multilayered Rosettes
Dr. Jon Weingart
Neurosurgery

Johns Hopkins University

600 N Wolfe St, Blalock 266, 
Baltimore, MD 
 (1.9 miles away)
410-502-4340
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jon Weingart is a Neurosurgery provider in Baltimore, Maryland. Dr. Weingart is rated as an Elite provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Awake Craniotomy, and Osteotomy.

Distinguished in Embryonal Tumor with Multilayered Rosettes
Dr. Gary L. Gallia
Neurosurgery
Distinguished in Embryonal Tumor with Multilayered Rosettes
Dr. Gary L. Gallia
Neurosurgery

Johns Hopkins University

600 N Wolf St, 
Baltimore, MD 
 (1.9 miles away)
410-955-5000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Gary Gallia is a Neurosurgery provider in Baltimore, Maryland. Dr. Gallia is rated as an Elite provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Olfactory Neuroblastoma, Chordoma, Pituitary Tumor, Endoscopic Transnasal Transsphenoidal Surgery, and Awake Craniotomy. Dr. Gallia is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Woodworth's expertise for a condition
ConditionClose
View All 11 Distinguished Conditions
View All 11 Advanced Conditions
View All 36 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile